Clinical evidence and rationale of mesoglycan to treat chronic venous disease and hemorrhoidal disease: a narrative review
-
By
-
Gaetano Gallo
-
Arcangelo Picciariello
-
Antonella Tufano
-
Giuseppe Camporese
-
February 14, 2024
-
0 min
Top Institutions in Surgery
Brief introduction explaining scope and methodology.
-
#1
Mayo Clinic
Rochester, MN
Key Differentiators
- Vascular Medicine
- Phlebology
- Clinical Research
-
#2
Cleveland Clinic
Cleveland, OH
Key Differentiators
- Vascular Surgery
- Phlebology
- Translational Research
-
#3
Stanford University Medical Center
Stanford, CA
Key Differentiators
- Vascular Medicine
- Phlebology
- Biomedical Research
-
#4
Imperial College London
London, N/A
Key Differentiators
- Vascular Medicine
- Phlebology
- Clinical Pharmacology
-
#5
University of Milan
Milan, N/A
Key Differentiators
- Vascular Medicine
- Phlebology
- Clinical Research
This content is an AI-generated, fully rewritten summary based on a published scholarly article. It does not reproduce the original text and is not a substitute for the original publication. Readers are encouraged to consult the source for full context, data, and methodology.